Is mTOR inhibitor good enough for treatment all tumors in TSC patients?

Samy L. Habib, Noor Y. Al-Obaidi, Maciej Nowacki, Katarzyna Pietkun, Barbara Zegarska, Tomasz Kloskowski, Wojciech Zegarski, Tomasz Drewa, Edward A. Medina, Zhenze Zhao, Sitai Liang

Research output: Contribution to journal › Review article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Is mTOR inhibitor good enough for treatment all tumors in TSC patients?'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Veterinary Science and Veterinary Medicine